Revenue Cycle Matters

Price Transparency Updates

Update to Regulations for Price Transparency

Over the summer we discussed in a blogpost, “Executive Order Reduces HHS Time for Transparency,” the order issues from the current administration to make pricing more accessible for patients to be able to shop around for common outpatient procedures. November 15th, CMS announced two proposed regulations intended to follow through on this order. One is

Update to Regulations for Price Transparency Read More »

drugmakers

Ruling Against First Pharmaceutical Company in Opioid Lawsuit

For the first time, a pharmaceutical company, Johnson & Johnson, has been ordered to pay a substantial sum for their role in the opioid crisis in Oklahoma. While the opioid epidemic is no doubt a nationwide crisis, Oklahoma has been particularly devastated by the highly addictive pain killer. There have reportedly been over 6,000 deaths

Ruling Against First Pharmaceutical Company in Opioid Lawsuit Read More »

executive order

Executive Order Reduces HHS Time for Transparency

An executive order issued this week calls for the U.S. Department of Health and Human Services (HHS) to write the hospital requirements on price transparency in the next 60 days. This should mandate “standard charge information, including charges and information based on negotiated rates and for common or shoppable items.” But what are common or

Executive Order Reduces HHS Time for Transparency Read More »